Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This finding dramatically expands therapeutic options for androgen deficiency, which affects a significant proportion of the male population at an advanced age
Oligonucleotide drugs represent a new modality for treatment of obesity, and all candidates are currently in Phase I trials
Carcinogenesis 36, 390399
BPC-157 mechanism of action: How it works in your body Understanding BPC-157s mechanisms of action can give you an idea of why this peptide has become so popular for healing and recovery
Evecxias lead drug candidate EVX-101 enables sufficient and sustained 5-HTP exposure at twice daily oral dosing, to treat patients with depression or OCD responding inadequately to first-line antidepressants
US$ 20.28
US$ 20.84
US$ 20.68
US$ 20.68
US$ 28.60
US$ 24.50
US$ 20.70
US$ 20.60
